General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors

Pathology and Oncology Research

Volumn 8, Issue 4, 2002, Pages 262-269

  Canöz, Özlem ^a   Belenli, Olcay ^b   Patiroglu, Tahír E ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Gastric carcinoma; HSP70; NK cell; Prognostic factors

Indexed keywords

HEAT SHOCK PROTEIN 70;

ADULT; ADVANCED CANCER; ARTICLE; ATROPHIC GASTRITIS; CANCER INVASION; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY CANCER; FEMALE; GASTRECTOMY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PROGNOSIS; STOMACH CARCINOMA; TUMOR VOLUME;

GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 0037001673     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03036742     Document Type: Article

References (38)

1. Davessar K, Pezzullo JC, Kessimian N, et al: Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications. Hum Pathol 21:325-332, 1990
2. Grabiec J, Owen DA: Carcinoma of the stomach in young persons. Cancer 56:388-390, 1985
3. Lauren PA, Nevalainen T.I: Epidemiology of intestinal and diffuse types of gastric carcinoma. Cancer 71:2926-2933, 1993
4. Lundergardh G, Lindgren A, Rohul A, et al: Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951. Br J Cancer 64:1182-1186, 1991
5. Antonioli DA, Goldman H. Changes in the location and type of gastric adenocarcinoma Cancer 50:775-781, 1982
6. Zanghieri G, Di Gregorio C, Sacchetti C, et al. Familial occurence of gastric cancer in the 2-year experience of a population-based registry. Cancer 66:2047-2051, 1990
7. Lu XP, Omar RA, Chang WWL. Immunocytochemical expression of the 70 kD heat-shock protein in ischaemic bowel disease, J Pathol 179:409-413, 1996
8. th ed). WB Saunders Company, Philadelphia 1994, pp 21, 779-783.
9. Robert J, Menoret A, Basu S, et al: Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70. Eur J Immunol 31:186-195, 2001
10. Monson JRT, Ramsden CW, Giles GR, Brennan TG. Lymphokin activated killer (LAK) cells in patients with gastrointestinal cancer. Gut 28:1420-1425, 1987
11. Coca S, Perez-Piqueras J, Martinez D, et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 79:2320-2328, 1997
12. Lauren P: The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma. Acta Pathol Microbiol Immunol Scand [B] 64:31-49, 1965
13. Holmes EC: Immunology of tumor infiltrating lymphocytes. Ann Surg 201:158-163, 1985
14. Nakamura K, Ueyama T, Yao T, et al: Pathology and prognosis of gastric carcinoma. Cancer 70:1030-1037, 1992
15. Setala LP, Kosma VM, Marin S, et al: Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmocytic infiltration. Br J Cancer 74:766-772, 1996
16. nd ed). Raven Press, New York pp 188-214, 1993
17. Sipponen P, Kekki M, Siurala M: Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Cancer 52:1062-1068, 1983
18. Iida F, Kusama J: Gastric carcinoma and intestinal metaplasia. Cancer 50:2854-2858, 1982
19. Huang CB, Xu J, Huang JF, Meng XY: Sulphomucin colonic type intestinal metaplasia and carcinoma in the stomach. Cancer 57:1370-1375, 1986
20. Hattori T: Devolepment of adenocarcinomas in the stomachs. Cancer 57:1528-1534, 1986
21. Oohara T Tohma H, Aono G, et al: Intestinal metaplasia of the regenerative epithelia in 549 gastric ulcers. Hum Pathol 14:1066-1071, 1983
22. Filipe MI, Potet F, Bogomoletz WV, et al. Incomplete sulphomucin secreting intestinal metaplasia for gastric cancer. Gut 6:1319-1326, 1985
23. Tanaka F, Yamaguchi K, Urano Y: Statistical analysis of the surgical materials of stomach. Cancer 59:1978-1982, 1987
24. Murayama H, Kikuchi M, Enjoji M, et al: Changes in gastric mucosa that antedate gastric carcinoma. Cancer 66:2017-2026, 1990
25. Karnes WE, Samloff IM, Sivrala M, Kekki M: Positive antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 101:167-174, 1991
26. Go MF: What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 113:15-20, 1997
27. Shibata T, Imoto I, Ohuchi Y, et al: Helicobacter pylori infection in patients with gastric carcinoma in biopsy and surgical resection specimens. Cancer 77:1044-1049, 1996
28. Lee PM, Jang JJ, Kim JS, et al: Association of Helicobacter pylori infection with gastric adenocarcinoma. Jpn J Cancer Res 89:597-603, 1998
29. Wee A, Kang JY, Teh M: Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia, and tumour histology. Gut 33:1029-1032, 1992
30. Asaka M, Takeda H, Sugiyama T, Kato M: What role does Helicobacter pylori play in gastric cancer? Gastroenterology 113:56-60, 1997
31. Multhoff G, Botzler C, Jennen L, et al. Heat-shock protein 72 on tumor cells. J Immunol 158:4341-4350, 1997
32. Kawanishi K, Shiozaki H, Doki Y, et al: Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 85:1649-1657, 1999
33. Park CS, Joo IS, Song SY, et al: An immunohistochemical analysis of heat shock protein 70, p 53 and estrogen status in carcinoma of the uterine cervix. Gynecol Oncol 74:53-60, 1999
34. Ciocca DR, Clark GM, Tandon AK, et al: Heat shock protein hsp70 in patient with axillary lymph node-negative breast cancer: prognostic implications. J Nat Cancer Ins 85:570-574, 1996
35. Chin Y, Janseens J, Vandepitte J, et al. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res 12:1463-1466, 1992
36. Brittenden J, Heys SD, Ross J, Eremin O: Natural killer cells and cancer. Cancer 77:1226-1243, 1996
37. Toliohu Th, Stravoravdi P, Polyzonis M, Vakalikos J: Natural killer cell activation after interferon administration in patients with metastatic renal cell carcinoma. Eur Urol 29:252-256, 1996
38. Karimine N, Arinaga S, Inove H, et al: Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients. Clin Exp Immunol 96:484-490, 1994